traffic analytics Rx&D - Canada's Research Based Pharmaceutical Companies
  Rx&DAbout Rx&DPharmaceutical Community
PublicationsMedia CentreStakeholders & PartnershipsMember's Login
 
 
 
  Forgot Password?
  Account Application
Rx&D HomeFrançaisContact Us
Useful LinksSite Map
  Pharmaceutical Community

Code of Conduct - Question & Answers

6. Donations - March 2005
 

Question 1:

As we have discussed the Fredericton Medical Centre in Fredericton, N.B. has been charging reps. for the use of their board room for a number of years for L&Ls, whether they be presentations by the reps. themselves or for speaker's programs sponsored by a company. It is apparent that various companies have taken various approaches to the payment of this charge since the Rx&D guidelines have come into place. It seems that there are three avenues being taken:

  1. some companies have simply decided to stop paying for the room as they have deemed it a violation of the code as it is, in their judgment, paying for access to physicians, some of these companies have asked for their deposit back and thus have lost their booking,
  2. some reps. have continued to pay the money, with or without their company's blessing, if the company has frowned on the payment the reps. have found ways to "bury" the cost, i.e., by rolling the cost into the meal itself (the cost of the meal is significant as up to 25-35 physicians can come for the food as it is "open" to everyone, even if the topic is of no interest or value to those MDs, nurses and receptionists have also indulged themselves at these luncheons so the numbers are indeed large)
  3. some companies have decided that the payment is acceptable if indeed the L&L is in the form of a speaker's program.

It would seem to me that a firm and consistent decision ought to be made concerning this clinic so that some companies are not gaining a significant advantage over others with respect to MD accessibility there. Either we all pay, regardless of the form of the luncheon, or none of us pay. I think Rx & D has to take a stand and make a decision that is binding on all member companies. Once a decision is arrived at then this should be specifically communicated to the clinic MDs. They then can decide if they will entertain reps. for L&Ls with no charge for the room, regardless of the form of the L&L.

Response:
That type of payment is not acceptable under our current Code. It has again been brought to the attention of Rx&D that various clinics have implemented a policy whereby pharmaceutical representatives are charged a "rental fee" for the use of a room within the clinic for the purpose of making educational presentations and/or convening meetings such as 'lunch and learn' sessions. Rx&D has also been informed of a recurrence of the practice whereby some clinics and hospitals are requesting a fee or donation, for example to the institution's library, in return for which, representatives are granted access to healthcare professionals or the ability to display their products within the institution.

Rx&D member companies would like to take this opportunity to remind the clinics administration of the following provisions of the Rx&D's Code (ed. January 2005):

  • Section 6.1.3. “Companies must never provide a donation, directly or indirectly, in order to have access to a healthcare professional.”
  • Section 8.2.7. “Under no circumstances shall company representatives pay a fee in order to gain access to a healthcare practitioner.”

The clinics administration is asked to collaborate with member companies in adhering to the principles of the Rx&D Code of Conduct.


Revised: June 06, 2005
 
 
Back to top

Home | About Rx&D | Pharmaceutical Community | Publications | Media Centre | Stakeholders & Partnerships
Useful Links | Français | Contact Us | Site Map

55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Tel.: (613) 236-0455 Reception Fax: (613) 236-6756
Strategic Affairs & Communications Fax: (613) 236-6861
Federal Affairs Fax: (613) 236-7919
© 2007 Rx&D Terms and Conditions of Use
All Rights Reserved